Phase I/II Study of GM-CSF DNA as an Adjuvant for a Multipeptide Cancer Vaccine in Patients With Advanced MelanomaMiguel‐Angel Perales, Jedd D. Wolchok, Gregor Manukian et al.|Molecular Therapy|2008Cited by 100
Phase II trial of extended-dosing temozolomide in patients with melanomaPetra Rietschel, Paul B. Chapman, Samuel Ejadi et al.|Journal of Clinical Oncology|2006Cited by 0
Phase II trial of extended-dosing temozolomide in patients with melanomaPetra Rietschel, P. B. Chapman, Katy Smith et al.|Journal of Clinical Oncology|2007Cited by 0